Related Experiment Video
Updated: May 26, 2026
13:56
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development
E Guzmán-Olea1, V H Bermúdez-Morales, O Peralta-Zaragoza
1Division of Chronic Infections and Cancer, Research Center for Infectious Diseases, Instituto Nacional de Salud Pública, Avenida Universidad No. 655, Cuernavaca 62100, Morelos, Mexico.
Journal of Oncology
|January 6, 2012
Summary
Persistent high-risk human papillomavirus (HPV) infection causes cervical cancer (CC). Understanding how HPV evades the immune system reveals potential molecular therapies to inhibit tumor immune escape and prevent CC progression.
Area of Science:
- Oncology
- Immunology
- Virology
Background:
- Persistent high-risk human papillomavirus (HPV) infection is the primary cause of cervical cancer (CC).
- Disease progression involves complex interactions between HPV, host immunity, and various environmental, genetic, and social factors.
- The host immune response is crucial for clearing HPV infections and preventing the development of precursor lesions and CC.
Purpose of the Study:
- To review recent research on the molecular mechanisms of HPV immune evasion.
- To identify potential molecular targets for therapeutic intervention against HPV-induced immune escape.
Main Methods:
- Literature review of recent scientific research.
- Analysis of molecular mechanisms underlying HPV immune evasion.
- Identification of potential therapeutic targets.
Main Results:
- HPV-infected cells employ sophisticated mechanisms to evade host immune surveillance.
- Specific molecular pathways are critical for tumor immune escape in HPV-associated CC.
- Several potential targets for molecular therapies aimed at overcoming immune evasion have been identified.
Conclusions:
- Targeting molecular mechanisms of immune evasion is a promising strategy for treating HPV-associated CC.
- Further research into these targets could lead to novel therapeutic approaches to inhibit tumor immune escape and improve CC outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...